JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Literature - Publication Review
All-in-one CRISPR-knockout screening for identifying drug-sensitive genes linked to apoptosis and vascular mimicry in colorectal cancer cells
Discover how scientists from TaiRx Inc. and Revvity preclinical services teamed up to explore efficacy improvements for a novel anti-cancer drug in our literature review.
In this literature, you will:
- Find out how CRISPR screening can be used to identify key genes and pathways of importance
- Learn how the team’s approach was applied to identify robust, actionable hits
- See data from a deeper dive analysis into the mTOR pathway
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
All-in-one CRISPR-knockout screening for identifying drug-sensitive genes linked to apoptosis and vascular mimicry in colorectal cancer cells